Pathogenesis of Epstein-Barr virus and malignancies

Seminars in Virology

Volumn 7, Issue 5, 1996, Pages 315-323

  Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

EBV; Lymphoma; Nasopharyngeal carcinoma; Transformation

Indexed keywords

MEMBRANE PROTEIN; VIRUS PROTEIN;

BONE MARROW; BURKITT LYMPHOMA; CARCINOGENESIS; CELL GROWTH; CELL TYPE; EPSTEIN BARR VIRUS; GENE MUTATION; HERPES VIRUS; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE TRANSFORMATION; LYMPHOMA; NASOPHARYNX CARCINOMA; OROPHARYNX; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; REVIEW; VIRUS CELL TRANSFORMATION; VIRUS EXCRETION; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION;

HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 0030267198     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1996.0039     Document Type: Review

References (72)

1. 1. Kieff E (1996) Epstein-Barr virus and its replication, in Virology, Third Edition (Fields B, Knipe D, Howley P et al, eds) pp 2343-2396. Lippincott-Raven Publishers, Philadelphia
2. 2. Henle W, Henle G (1979) Seroepidemiology of the virus, in The Epstein-Barr Virus (Ep stein MA, Achong BG, eds) pp 61-78. Springer, Berlin
3. 3. Nonoyama M, Pagano J (1973) Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's Lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature 242:44-47
4. 4. Wolf H, zur Hausen H, Becker Y (1973) EBV viral genomes in epithelial nasopharyngeal carcinoma cells. Nature Biol 244:245-267
5. 5. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, McClain K, Simmons RL, Najerian JS (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation: clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198:356-369
6. 6. Miller G (1990) Epstein-Barr virus: biology, pathogenesis, and medical aspects, in Virology, Second Edition (Fields B, ed.) pp 1921-1958. Raven Press, New York
7. 7. Raab-Traub N, Hood R, Yang CS, Henry B, Pagano JS (1983) Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 48:580-590
8. 8. Fahraeus R, Fu JL, Ernberg I, Finke I, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329-338
9. 9. Young L, Dawson C, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson A (1988) Epstein-Barr virus expression in nasopharyngeal carcinoma. J Gen Virol 69:1051-1065
10. 10. Gilligan K, Sato H, Rajadurai P, Busson P, Young L, Rickinson A, Tursz T, Raab-Traub N (1990) Novel transcription from the Epstein-Barr virus terminal EcoR1 fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 64:4948-4956
11. 11. Rickinson AB, Kieff E (1996) Epstein-Barr virus, in Virology, Third Edition (Fields, B, Knipe D, Howley P et al, eds) pp 2343-2396. Lippincott-Raven Publishers, Philadelphia
12. 12. Miller WE, Earp HS, Raab-Traub N (1995) The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 69:4390-4398
13. 13. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Detection of Epstein-Barr virus DNA and RNA in human pharyngeal epithelial cells. New Engl J Med 310:1225-1230
14. 14. Gratama JW, Oosterveer MAP, Zwaan FE, Lepooutre J, Klein G, Ernberg I (1988) Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci USA 85:8693-8696
15. 15. Pope JH (1967) Establishment of cell lines from peripheral leukocytes in infectious mononucleosis. Nature 216:810-811
16. 16. Gavioli R, Kurilla M, Campos-Lima P-O, Wallace L, Dolcetti R, Murray R, Rickinson A, Masucci M (1993) Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenetics in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 67:1572-1578
17. 17. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB (1992) Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157-168
18. 18. Appolloni A, Moss D, Stumm R, Burrows S, Suhrbier A, Misko I, Schmidt C, Sculley T (1992) Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus. Eur J Immunol 22:183-189
19. 19. Henle G, Henle W, Diehl V (1968) Relation of Burkitt tumor associated Herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 59:94-101
20. 20. Given D, Yee D, Griem K, Kieff E (1979) DNA of Epstein-Barr virus. V. Direct repeats at the ends of Epstein-Barr virus DNA. J Virol 30:852-862
21. 21. Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889
22. 22. Gulley M, Raphael M, Lutz CT, Ross DW, Raab-Traub N (1992) Epstein-Barr virus integration in human lymphomas and in lymphoid cell lines. Cancer 70:185-191
23. 23. Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806-3810
24. 24. Srinivas SK, Sixbey J (1995) Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J Virol 69:8155-8158
25. 25. Wilson J, Bell JL, Levine AJ (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 15:3117-3126
26. 26. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla, Masucci MG (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:686-688
27. 27. Cohen J, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86:9558-9562
28. 28. Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson A (1989) Distinction between Epstein-Barr virus type-A (EBNA-2A) and type-B (EBNA-2B) isolates extends to the EBNA-3 family of nuclear proteins. J Virol 63:1031-1039
29. 29. Sample J, Young L, Martin B, Chatman E, Rickinson A, Kieff E (1990) Epstein-Barr virus type 1 and type 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 64:4084-4092
30. 30. Kaye K, Izumi K, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150-9154
31. 31. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840
32. 32. Fries K, Miller WE, Raab-Traub N (1996) Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol, in press
33. 33. Moorthy R, Thorley-Lawson DA (1993) Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP1. J Virol 67:2637-2645
34. 34. Miller WE, Edwards RH, Walling DM, Raab-Traub N (1994) Sequence variation in the Epstein-Barr virus latent membrane protein LMP1. J Gen Virol 75:2729-2740
35. 35. Mosialos G, Birkenbach M, Yalamanchili R, Van Arsdale T, Ware C, Kieff E (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399
36. 36. Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein 1 (LMP1) mediates activation of NFkB and cell surface phenotype via two effector regions in its carboxy terminal cytoplasmic domain. Oncogene 10:549-560
37. 37. Miller WE, Mosialos G, Kieff E, Raab-Traub N (1996) EBV LMP1 induction of the EGFR is mediated through a TRAF signalling pathway distinct from NF-κB activation. J Virol, in press
38. 38. Sample J, Liebowitz D, Kieff E (1989) Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol 63:933-937
39. 39. Miller CL, Lee JH, Kieff E, Longnecker R (1994) An integral membrane protin (LMP2) blocks reactivations of Epstein-Barr virus from latency following surface immunoglobulin cross-linking. Proc Natl Acad Sci USA 91:772-776
40. 40. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Enberg I, Griffin B (1989) EBV gene expression in an NPC-related tumour. EMBO J 8:2639-2651
41. 41. Gilligan K, Rajadurai P, Lin JC, Busson P, Abdel-Hamid M, Prasad U, Tursz T, Raab-Traub N (1991) Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein preferentially expressed in epithelial cells. J Virol 65:6252-6259
42. 42. Sadler RH, Raab-Traub N (1995) Structural analyses of the Epstein-Barr virus BamHI A Transcripts. J Virol 69:1132-1141
43. 43. Arrand JR, Rymo L (1982) Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J Virol 41:376-389
44. 44. Swaminathan S, Tomkinson B, Kieff E (1991) Recombinant Epstein-Barr virus deleted for small RNA (EBER) genes transforms lymphocytes and replicates in vitro
45. 45. Pathmanathan R, Prasad U, Chandrika G, Saler RH, Flynn K, Raab-Traub N (1995) Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 146:1355-1367
46. 46. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N (1990) Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA 87:8790-8794
47. 47. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743-2751
48. 48. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson K, Ritz J, Shapiro R, Rickinson A, Kieff E, Cohen J (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. New Engl J Med 321:1080-1085
49. 49. Qu L, Rowe DT (1992) Epstein-Barr virus latent gene expression I uncultured peripheral blood lymphocytes. J Virol 66:3715-3724
50. 50. Cohen J (1991) Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 70:137-160
51. 51. Heslop HE, Brenner MK, Rooney C (1994) Administration of neomycin resistance gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Human Gene Ther 5:381-397
52. 52. Papdapoulos EB, Ldanyi M, Emanuel D (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lympho-proliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 330:1185-1191
53. 53. Rooney CM, Smith CA, Brenner MK, Heslop HE (1995) Prophylaxis and treatment of Epstein-Barr virus lymphoproliferative disease using genetically modified cytotoxic T lymphocytes. Lancet 345:9-13
54. 54. Burkitt D (1962) A children's cancer dependent upon climatic factors. Nature 194:232-234
55. 55. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RW, Croce C (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 79:7824-7827
56. 56. O'Connor GT, Rappaport H, Smith EB (1965) Childhood lymphoma resembling Burkitt's lymphoma in the United States. Cancer 18:411-417
57. 57. Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW (1996) Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 173:529-535
58. 58. Raab-Traub N (1993) Epstein-Barr virus and nasopharyngeal carcinoma. Cancer Biol 3:297-307
59. 59. de The' G (1982) Epidemiology of Epstein-Barr virus and associated diseases, in The Herpesviruses (Roizman B, ed.) pp 25-87. Plenum Press, New York
60. 60. Ho JHC (1972) Current knowledge of the epidemiology of nasopharyngeal carcinoma, in Oncogenesis and Herpesviruses (Biggs P, de The' G, Payne L, eds) pp 357-366. IARC, Lyon
61. 61. Armstrong RW, Armstrong MH, Yu MC, Henderson BE (1983) Salted fish and inhalants as risk factors for carcinoma in Malaysian Chinese. Cancer Res 43:2967-2970
62. 62. Poirier S, Ohshima H, De The' G, Hubert A, Bourgade MC, Bartsch H (1987) Volatile nitrosamine levels in common foods from Tunisia, South China, and Greenland, high risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 39:292-296
63. 63. Huang D, Lo KW, Choi PHK, Ng AYT, Tsai SY, Yiu GKC, Lee JCK (1991) Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet 54:91-99
64. 64. Huang D, Lo KW, van Hasselt A, Woo JKS, Choi PHK, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JCK (1994) A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 54:4003-4006
65. 65. Pathmanathan R, Prasad U, Salder RH, Flynn K, Raab-Traub N (1995) Preinvasive neoplasia of the nasopharynx: A clonal proliferation of EBV-infected cells. New Engl J Med 333:695-698
66. 66. Henle G, Henle W (1979) Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 17:1-17
67. 67. Sixbey JW, Yao QY (1992) Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255:1578-1580
68. 68. Arvanitakis L, Yaseen N, Sharma S (1995) Latent membrane protein 1 induces cyclin D2 expression, Rb hyperphosphorylation, and loss of TGF-β1-mediated growth inhibition in EBV-positive B cells. J Immunol 155:1047-1056
69. 69. Sun Y, Hegameyer G, Colburn N (1993) Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. Oncogene 8:791-795
70. 70. Effert P, McCoy R, Abdel-Hamid M, Flynn K, Zhang Q, Busson P, Tursz T, Liu E, Raab-Traub N (1992) Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 66:3768-3775
71. 71. Edwards RH, Raab-Traub N (1993) Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas. J Virol 68:1309-1315
72. 72. Canman CE, Wolff AC, Chen CY, Fornance AJ, Kastan MB (1994) The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res 54:5054-5058